MRC Molecular Haematology Unit
We aim to understand how mature blood cells are normally made from stem cells and how this is perturbed in common blood disorders. Ultimately, our purpose is to improve the prognosis of patients with inherited and acquired blood diseases.
Unit Director
MRC MHU postdoc named rising star in biobusiness
Congratulations to Dr Danuta Jeziorska, named one of the Rising Stars in BioBeat’s ’50 Movers and Shakers in BioBusiness 2018’ report, for supporting innovation from concept to market.
Read more£635,000 towards new Therapy Acceleration Laboratory
Deutsche Bank employees across the UK raised this generous sum via their ‘One Day’ initiative, in collaboration with Cure Leukaemia
Read moreNew technique to analyse cancer cells' life history
Analysing tumours cell by cell will help develop personalised cancer treatments.
Read moreLatest Publications
-
Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds.
Cruz-Migoni A. et al, (2019), Proc Natl Acad Sci U S A
-
SCL/TAL1 cooperates with Polycomb RYBP-PRC1 to suppress alternative lineages in blood-fated cells.
Chagraoui H. et al, (2018), Nat Commun, 9
-
Bi-directional signaling by membrane-bound KitL induces proliferation and coordinates thymic endothelial cell and thymocyte expansion.
Buono M. et al, (2018), Nat Commun, 9
-
Single-allele chromatin interactions identify regulatory hubs in dynamic compartmentalized domains.
Oudelaar AM. et al, (2018), Nat Genet
-
A tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactions.
Brown JM. et al, (2018), Nat Commun, 9
Latest News
-
New technique to analyse cancer cells' life history
12 February 2019
-
First MRC WIMM postdoc symposium a success
29 January 2019
-
MRC MHU postdoc named rising star in biobusiness
14 December 2018
-
MRC WIMM students win RDM graduate prize
3 December 2018